Anne Montgomery (@BPI_Anne) header
Anne Montgomery (@BPI_Anne) profile picture

Anne Montgomery

@BPI_Anne

BioProcess International magazine editor in chief -- always looking for hot topics and people eager to write about them!

 Oregon, USA
Joined July 2016
  • Tweets208
  • Following206
  • Followers180
3Media
Photo by Anne Montgomery (@BPI_Anne)Photo by Anne Montgomery (@BPI_Anne)
An unexpected discovery turns into a useful tool for #CRISPR technology .@AprilPawluk .@UofT .@lnhandly ow.ly/cAQo308R2dU
Image from BioTechniques (@MyBioTechniques)
12
8
Add your voice to BPI's 15th-anniversary State of the Industry issue (June) - take our survey! (good prizes, too) ow.ly/oIID30aQ6hF
Anne Montgomery retweeted
Lonza Drug Product (@LonzaDPS) profile picture
Lonza Drug Product@LonzaDPS11 Apr 2017
#LonzaDrugProduct expert M. Jahn featured in @BioProcessIntl ebook on Extractables & Leachables. Read ebook here: ow.ly/nmkt30aJW0U
Image from Lonza Drug Product (@LonzaDPS)
1
1
1
Anne Montgomery retweeted
Amgen 🧪🔬🧬 (@Amgen) profile picture
Amgen 🧪🔬🧬
@Amgen11 Apr 2017
This month, we’re busting the craziest #cholesterol and #heartdisease myths to help show healthy lifestyle tips! #AmgenCV
5
8
1
8
How are new technologies driving innovations in health sciences? Download the report at ow.ly/ADTk30aMaQ2 #SCORR #KNect365
Be part of the conversations at “Cell and Gene Therapy Exchange” for regulatory, business, and patient advocates ow.ly/IOnO30aMayw
Nice graphic and short commentary on the progress and evolution of US biosimilars #GaBi ow.ly/X1V530aMarQ
Kudos to Patheon for leading in new drug approvals! ow.ly/4CX730aMapH
Patheon Leads in New Drug Approvals

Patheon Leads in New Drug Approvals

The company is an NDA leader, according to PharmSource CMO Scorecard.

pharmasalmanac.com
Kite Pharma and IsoPlexis collaborate toward a single-cell platform to predict patient response to T-Cell Therapy. ow.ly/gSzE30aMaeX
A good summary of recent approval recommendations from the EMA -- good to see orphan drugs in the mix. ow.ly/Pj9a30aesHD
BPI's Sr. Technical Editor, Cheryl Scott, explains the added Product Development theme in our 15th anniversary year, ow.ly/WjOr30a5Bor
Best practices (and more) for combination-product development in BPI’s March issue, ow.ly/vy8Q30a5Bdm #CASSS #bioprocess
1
So how big IS “big data?” And why should you care? Read about it in BPI’s March issue! ow.ly/azb230a5B35
BPI March issue featured report now available: Outsourcing: Who, What, When, Where, and How? ow.ly/KV8F30a5AS6
Also on the topic: Watch for BPI's March article on advanced gene-editing techologies -- available online soon! #bioprocess xitter.gq/BioRadLifeSci/status/8…
Bio-Rad Life Science (@BioRadLifeSci) profile pictureBio-Rad Life Science@BioRadLifeSci16 Mar 2017
Developing new #therapeutics? Learn how #CRISPR, is shaking up Drug Discovery and Development? bit.ly/2nwNQ1M #genes
Image from Bio-Rad Life Science (@BioRadLifeSci)
Another good course offering: “Commissioning and Qualification for New and Renovated Facilities” #NIBRT #bioprocess ow.ly/34g7309YVoR
Anne Montgomery retweeted
EBD Group (@EBDgroup) profile picture
EBD Group@EBDgroup6 Mar 2017
Access a world of opportunities at our premier springtime partnering conference #BIOEuropeSpring REGISTER NOW >> spr.ly/60188pQna
Image from EBD Group (@EBDgroup)
1
Pros and cons of additional 6 months of exclusivity for manufacturers of biosimilars? Implications? ow.ly/dbxQ309Erx4
Anne Montgomery retweeted
EBD Group (@EBDgroup) profile picture
EBD Group@EBDgroup6 Mar 2017
#BIOEuropeSpring #RareDisease Panel Discussion 🎤 w/ @CriticalOutcome, @CincyChildrens, @CoteOrphan, @GlobalGenes > bit.ly/2lx8VfPc
Image from EBD Group (@EBDgroup)
2
2
Load more